Triple-negative breast cancer trials in India
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Where
- Hyderabad, Mumbai
- Age
- 18 years and over
- People
- 2,400 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06966700 · EU 2024-520190-12-00 - Phase 3Taking peopleA Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Where
- Calicut, Chennai, Jaipur, Kochi, Kolkata, Kottayam, Marg Jaipur, Mohali, Mysuru, Nagpur, Nashik, New Delhi, Puducherry, Surat, Thiruvananthapuram, Vadodara, Visakhapatnam
- Age
- 18 years and over
- People
- 625 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06103864 - Phase 3Taking peopleNuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer
- Where
- Erode, Jalgaon, Kanpur, Mysore, Pune, Visakhapatnam
- Age
- 18 years to 65 years
- People
- 250
- Run by
- Natureceuticals Sdn Bhd
See details and how to joinNCT07669467 - Phase 2/3Taking peopleA Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Where
- Chennai, Hyderabad, Mumbai, Nagpur, New Delhi, Varanasi
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06926868 · EU 2024-519871-24-00 - Phase 2Taking peopleEfficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
- Where
- Bangalore, Hyderabad, Kolkata, Madurai, Mumbai, Pune, Vijayawada
- Age
- 18 years and over
- People
- 40
- Run by
- Rhizen Pharmaceuticals SA
See details and how to joinNCT06189209 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
- Where
- Vadodara
- Age
- 18 years to 65 years
- People
- 657 worldwide
- Run by
- Jina Pharmaceuticals Inc.
See details and how to joinNCT03671044